Lifecore Biomedical (LDE) Stock Statistics & Valuation Metrics

Lifecore Biomedical has a market cap or net worth of €142.77M. The enterprise value is €481.27.

Lifecore Biomedical has 37,509,407 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lifecore Biomedical’s return on equity (ROE) is 2.17 and return on invested capital (ROIC) is -0.60%.

The current PE Ratio of Lifecore Biomedical is ―. Lifecore Biomedical’s PEG ratio is 0.32.

In the last 12 months, Lifecore Biomedical had revenue of 129.46M and earned -30.79M in profits. Earnings per share was -0.92.

In the last 12 months, operating cash flow was 17.38M and capital expenditures -6.91M, giving a free cash flow of 10.47M billion.

Lifecore Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Lifecore Biomedical upcoming earnings date is Aug 6, 2026, After Close (Confirmed).

Lifecore Biomedical as a current ratio of 3.49, with Debt / Equity ratio of 722.60%

In the past 12 months, Lifecore Biomedical has paid 577.71K in taxes.

Lifecore Biomedical EV to EBITDA ratio is 48.19, with an EV/FCF ratio of 63.76.

Lifecore Biomedical has €20.80M in cash and marketable securities with €150.14M in debt, giving a net cash position of -€129.35M billion.

Gross margin is 31.17%, with operating margin of -0.97%, and net profit margin of -23.78%.

The average price target for Lifecore Biomedical is €5.68, which is 11.43% higher than the current price. The consensus rating is Strong Buy